iRxReminder Announces Enrollment of Initial Patients in Groundbreaking Tardive Dyskinesia Detection Study

CLEVELAND, Aug. 2, 2023 /PRNewswire/ — iRxReminder, LLC, a pioneer in medical adherence technology, is thrilled to announce the enrollment of its first patients in the innovative NIMH-funded study, the TDtectâ„¢ Diagnostic. The study leverages iRxReminder’s cutting-edge Internet of Things…